XML 33 R22.htm IDEA: XBRL DOCUMENT

Subsequent Event	6 Months Ended
Subsequent Event	Apr. 30, 2016
Subsequent Events [Abstract]
Subsequent Event	Subsequent Event Subsequent to our fiscal second quarter of 2016, on May 31, 2016, CooperSurgical acquired Reprogenetics UK, a genetics laboratory specializing in service offerings of preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD) used during the IVF process, for approximately $12.0 million. Subsequent to our fiscal second quarter of 2016, on May 25, 2016, CooperSurgical acquired the commercial assets of Recombine Inc., a clinical genetic testing company specializing in carrier screening for approximately $85.0 million. Subsequent to our fiscal second quarter of 2016, on May 4, 2016, CooperSurgical acquired Kivex Biotec A/S (K-Systems), a manufacturer and distributor of equipment for IVF clinics, for approximately $11.5 million.